Integral Health Asset Management LLC Boosts Position in Agilent Technologies, Inc. $A

Key Points

• Integral Health Asset Management LLC increased its stake in Agilent by 80% in Q3, buying 40,000 shares to hold 90,000 shares valued at about $11.55 million, part of broader institutional buying that included a new $395 million position by Norges Bank and large increases from AQR and Ameriprise.
• Agilent slightly missed quarterly estimates (EPS $1.36 vs. $1.37; revenue $1.80B vs. $1.81B) but revenue rose 7% year‑over‑year, management set FY 2026 EPS guidance of 5.90–6.04, and the company declared a $0.255 quarterly dividend (annual $1.02, ~0.9% yield).

Integral Health Asset Management LLC lifted its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 80.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,000 shares of the medical research company's stock after buying an additional 40,000 shares during the quarter. Integral Health Asset Management LLC's holdings in Agilent Technologies were worth $11,552,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of A. Norges Bank bought a new position in shares of Agilent Technologies in the second quarter worth $395,088,000. AQR Capital Management LLC boosted its position in shares of Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company's stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company's stock worth $277,807,000 after purchasing an additional 1,340,161 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company's stock valued at $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Finally, Troy Asset Management Ltd raised its stake in Agilent Technologies by 74.3% in the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company's stock valued at $282,967,000 after purchasing an additional 1,021,865 shares in the last quarter.

Agilent Technologies Price Performance

A opened at $111.60 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock's 50 day simple moving average is $130.34 and its 200 day simple moving average is $135.71. The firm has a market cap of $31.54 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 2.35 and a beta of 1.31. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies's dividend payout ratio is presently 22.52%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on A shares. Citigroup boosted their price target on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a "buy" rating in a research note on Tuesday, November 25th. Robert W. Baird raised their price objective on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an "outperform" rating in a research report on Tuesday, November 25th. The Goldman Sachs Group initiated coverage on shares of Agilent Technologies in a report on Tuesday, December 9th. They set a "buy" rating and a $170.00 price objective for the company. TD Cowen cut their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Finally, Wells Fargo & Company reduced their target price on Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating on the stock in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $161.20.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.